We are live on
!
Find out more
Wealthfront Advisers Portfolio holdings
AUM
$52B
Turnover
7.12%
1-Year Est. Return
24.53%
This Fund
S&P 500
This Quarter
Est. Return
+2.41%
1 Year Est. Return
+24.53%
3 Year Est. Return
+63.26%
5 Year Est. Return
+56.07%
10 Year Est. Return
–
AUM
$11.5B
AUM Growth
+$724M
(+6.7%)
Cap. Flow
+$471M
Cap. Flow
% of AUM
4.09%
Top 10 Holdings %
Top 10 Hldgs %
75.91%
Holding
508
New
28
Increased
298
Reduced
158
Closed
21
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$206M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$95.4M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$68.7M |
| 4 |
Vanguard Energy ETF
VDE
|
+$56.5M |
| 5 |
Schwab US Broad Market ETF
SCHB
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$88.4M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$49.8M |
| 3 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$6.38M |
| 4 |
Intel
INTC
|
+$2.08M |
| 5 |
Philip Morris
PM
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.79% |
| 2 | Financials | 1.77% |
| 3 | Technology | 1.65% |
| 4 | Healthcare | 0.99% |
| 5 | Communication Services | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Monster Beverage
MNST
$88.8B
| $441K | ﹤0.01% |
27,608
-480
| -2% | -$7.23K |
2018 Q4
2 quarters
|
|
402
Brown-Forman Class B
BF.B
$13.1B
| $435K | ﹤0.01% |
7,853
+100
| +1% | +$5.34K |
2018 Q4
2 quarters
|
|
403
Schwab Fundamental US Large Company Index ETF
FNDX
$28.1B
| $434K | ﹤0.01% |
33,258
+8,253
| +33% | +$106K |
2018 Q4
2 quarters
|
|
404
Ralph Lauren
RL
$23.3B
| $434K | ﹤0.01% |
3,824
-696
| -15% | -$83.4K |
2018 Q4
2 quarters
|
|
405
Stanley Black & Decker
SWK
$14B
| $430K | ﹤0.01% |
2,975
+508
| +21% | +$71.6K |
2018 Q4
2 quarters
|
|
406
Regeneron Pharmaceuticals
REGN
$82B
| $414K | ﹤0.01% |
1,324
-166
| -11% | -$55.3K |
2018 Q4
2 quarters
|
|
407
CBRE Group
CBRE
$39.2B
| $405K | ﹤0.01% |
7,892
+237
| +3% | +$11.8K |
2018 Q4
2 quarters
|
|
408
NOV
NOV
$6.64B
| $400K | ﹤0.01% |
18,015
-9,761
| -35% | -$236K |
2018 Q4
2 quarters
|
|
409
Xylem
XYL
$24.1B
| $389K | ﹤0.01% |
4,653
+350
| +8% | +$27.9K |
2018 Q4
2 quarters
|
|
410
Corteva
CTVA
$8.59B
| $381K | ﹤0.01% |
+12,895
| New | +$347K |
2019 Q2
0 quarters
|
|
411
Vulcan Materials
VMC
$32.7B
| $380K | ﹤0.01% |
2,771
+1,063
| +62% | +$136K |
2019 Q1
1 quarter
|
|
412
Martin Marietta Materials
MLM
$34.9B
| $379K | ﹤0.01% |
1,649
+349
| +27% | +$75.6K |
2018 Q4
2 quarters
|
|
413
Federal Realty Investment Trust
FRT
$9.18B
| $372K | ﹤0.01% |
2,890
-113
| -4% | -$15K |
2018 Q4
2 quarters
|
|
414
Hilton Worldwide
HLT
$77.2B
| $367K | ﹤0.01% |
3,752
+907
| +32% | +$82.3K |
2019 Q1
1 quarter
|
|
|
ETFC
415
DELISTED
E*Trade Financial Corporation
ETFC
| $366K | ﹤0.01% |
8,202
-484
| -6% | -$23.1K |
2018 Q4
2 quarters
|
|
416
Broadridge
BR
$19.7B
| $364K | ﹤0.01% |
2,852
+218
| +8% | +$26.3K |
2018 Q4
2 quarters
|
|
417
DELISTED
Interpublic Group of Companies
IPG
| $363K | ﹤0.01% |
16,079
-550
| -3% | -$12.2K |
2018 Q4
2 quarters
|
|
418
Teleflex
TFX
$5.43B
| $358K | ﹤0.01% |
1,082
+31
| +3% | +$9.36K |
2018 Q4
2 quarters
|
|
|
ATVI
419
DELISTED
Activision Blizzard
ATVI
| $358K | ﹤0.01% |
7,575
+1,370
| +22% | +$62.9K |
2018 Q4
2 quarters
|
|
420
Digital Realty Trust
DLR
$64.7B
| $355K | ﹤0.01% |
3,014
-57
| -2% | -$6.79K |
2018 Q4
2 quarters
|
|
421
Equifax
EFX
$18.9B
| $350K | ﹤0.01% |
2,586
+56
| +2% | +$7.02K |
2019 Q1
1 quarter
|
|
422
Labcorp
LH
$26.4B
| $344K | ﹤0.01% |
2,319
+223
| +11% | +$31.1K |
2019 Q1
1 quarter
|
|
423
Baker Hughes
BKR
$54B
| $341K | ﹤0.01% |
13,852
-20,064
| -59% | -$484K |
2018 Q4
2 quarters
|
|
424
Dentsply Sirona
XRAY
$1.76B
| $336K | ﹤0.01% |
5,763
+506
| +10% | +$27.2K |
2019 Q1
1 quarter
|
|
425
United Rentals
URI
$65.2B
| $333K | ﹤0.01% |
2,512
+176
| +8% | +$22.3K |
2018 Q4
2 quarters
|
|
Similar funds
Wealthfront Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, Wealthfront Advisers held 508 positions worth $11.5B, up 6.7% from $10.8B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Wealthfront Advisers deployed $471M of net new capital in Q2 2019, opening 28 new positions and adding to 298 existing holdings. Its largest new stake was Dow Inc: 24,993 shares worth $1.23M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 91% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $88.4M trimmed.
- Wealthfront Advisers's largest Q2 2019 buy was Dow Inc: 24,993 shares worth $1.23M.
- Wealthfront Advisers added most to Schwab International Equity ETF in Q2 2019, an estimated $206M increase.
- Wealthfront Advisers's biggest Q2 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $88.4M.
- Wealthfront Advisers fully exited Kroger in Q2 2019, selling an estimated $986K.
- Wealthfront Advisers's ten largest holdings make up 76% of its $11.5B portfolio in Q2 2019.
- Wealthfront Advisers opened 28 new positions and closed 21 in Q2 2019.
- Wealthfront Advisers's portfolio value rose 6.7% quarter-over-quarter to $11.5B.
Based on Wealthfront Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.